• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4 T细胞介导人源化小鼠高脂饮食诱导的非酒精性脂肪性肝病中肝纤维化的发展。

CD4 T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice.

作者信息

Her Zhisheng, Tan Joel Heng Loong, Lim Yee-Siang, Tan Sue Yee, Chan Xue Ying, Tan Wilson Wei Sheng, Liu Min, Yong Kylie Su Mei, Lai Fritz, Ceccarello Erica, Zheng Zhiqiang, Fan Yong, Chang Kenneth Tou En, Sun Lei, Chang Shih Chieh, Chin Chih-Liang, Lee Guan Huei, Dan Yock Young, Chan Yun-Shen, Lim Seng Gee, Chan Jerry Kok Yen, Chandy K George, Chen Qingfeng

机构信息

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

Genome Institute of Singapore, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

出版信息

Front Immunol. 2020 Sep 11;11:580968. doi: 10.3389/fimmu.2020.580968. eCollection 2020.

DOI:10.3389/fimmu.2020.580968
PMID:33013934
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7516019/
Abstract

Non-alcoholic fatty liver disease (NAFLD) has been on a global rise. While animal models have rendered valuable insights to the pathogenesis of NAFLD, discrepancy with patient data still exists. Since non-alcoholic steatohepatitis (NASH) involves chronic inflammation, and CD4 T cell infiltration of the liver is characteristic of NASH patients, we established and characterized a humanized mouse model to identify human-specific immune response(s) associated with NAFLD progression. Immunodeficient mice engrafted with human immune cells (HIL mice) were fed with high fat and high calorie (HFHC) or chow diet for 20 weeks. Liver histology and immune profile of HIL mice were analyzed and compared with patient data. HIL mice on HFHC diet developed steatosis, inflammation and fibrosis of the liver. Human CD4 central and effector memory T cells increased within the liver and in the peripheral blood of our HIL mice, accompanied by marked up-regulation of pro-inflammatory cytokines (IL-17A and IFNγ). depletion of human CD4 T cells in HIL mice reduced liver inflammation and fibrosis, but not steatosis. Our results highlight CD4 memory T cell subsets as important drivers of NAFLD progression from steatosis to fibrosis and provides a humanized mouse model for pre-clinical evaluation of potential therapeutics.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内呈上升趋势。虽然动物模型为NAFLD的发病机制提供了有价值的见解,但与患者数据仍存在差异。由于非酒精性脂肪性肝炎(NASH)涉及慢性炎症,且肝脏中CD4 T细胞浸润是NASH患者的特征,我们建立并表征了一种人源化小鼠模型,以确定与NAFLD进展相关的人类特异性免疫反应。将人免疫细胞植入免疫缺陷小鼠(HIL小鼠),并给予高脂高糖(HFHC)或普通饮食20周。分析HIL小鼠的肝脏组织学和免疫特征,并与患者数据进行比较。接受HFHC饮食的HIL小鼠出现肝脏脂肪变性、炎症和纤维化。我们的HIL小鼠肝脏和外周血中的人CD4中央记忆和效应记忆T细胞增加,同时促炎细胞因子(IL-17A和IFNγ)显著上调。在HIL小鼠中耗竭人CD4 T细胞可减轻肝脏炎症和纤维化,但不能减轻脂肪变性。我们的结果突出了CD4记忆T细胞亚群是NAFLD从脂肪变性进展为纤维化的重要驱动因素,并为潜在治疗药物的临床前评估提供了一种人源化小鼠模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/c6a40b98649f/fimmu-11-580968-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/04e59acabefd/fimmu-11-580968-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/3c44a8b9aaf3/fimmu-11-580968-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/9f7415c9333a/fimmu-11-580968-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/488d2fbfa400/fimmu-11-580968-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/6471c568b5fa/fimmu-11-580968-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/c6a40b98649f/fimmu-11-580968-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/04e59acabefd/fimmu-11-580968-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/3c44a8b9aaf3/fimmu-11-580968-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/9f7415c9333a/fimmu-11-580968-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/488d2fbfa400/fimmu-11-580968-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/6471c568b5fa/fimmu-11-580968-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca74/7516019/c6a40b98649f/fimmu-11-580968-g006.jpg

相似文献

1
CD4 T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice.CD4 T细胞介导人源化小鼠高脂饮食诱导的非酒精性脂肪性肝病中肝纤维化的发展。
Front Immunol. 2020 Sep 11;11:580968. doi: 10.3389/fimmu.2020.580968. eCollection 2020.
2
Blocking integrin αβ-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis.阻断整合素 αβ 介导的 CD4 T 细胞向肠道和肝脏的募集可保护小鼠免受西式饮食诱导的非酒精性脂肪性肝炎。
J Hepatol. 2020 Nov;73(5):1013-1022. doi: 10.1016/j.jhep.2020.05.047. Epub 2020 Jun 12.
3
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
4
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.抑制白细胞介素 11 信号通路可减少非酒精性脂肪性肝炎小鼠模型中的肝细胞死亡及肝纤维化、炎症和脂肪变性。
Gastroenterology. 2019 Sep;157(3):777-792.e14. doi: 10.1053/j.gastro.2019.05.002. Epub 2019 May 9.
5
Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.巨噬细胞 p38α 通过 M1 极化促进营养性脂肪性肝炎。
J Hepatol. 2019 Jul;71(1):163-174. doi: 10.1016/j.jhep.2019.03.014. Epub 2019 Mar 23.
6
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.半乳糖凝集素-3与白细胞介素-33/ST2轴在饮食诱导的脂肪性肝炎中的作用及相互作用
World J Gastroenterol. 2016 Nov 28;22(44):9706-9717. doi: 10.3748/wjg.v22.i44.9706.
7
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.Gasdermin D 在人类和小鼠的非酒精性脂肪性肝炎中作为细胞焦亡的效应蛋白发挥关键作用。
J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
8
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.FATZO小鼠是2型糖尿病的下一代模型,在喂食添加了果糖的西式饮食时会发展为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)。
BMC Gastroenterol. 2019 Mar 18;19(1):41. doi: 10.1186/s12876-019-0958-4.
9
Mesenchymal stem cells reverse high‑fat diet‑induced non‑alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice.间充质干细胞通过抑制 CD4+T 淋巴细胞逆转高脂饮食诱导的小鼠非酒精性脂肪性肝病。
Mol Med Rep. 2018 Mar;17(3):3769-3774. doi: 10.3892/mmr.2017.8326. Epub 2017 Dec 20.
10
Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.肥胖小鼠饮食诱导的非酒精性脂肪性肝炎和肝纤维化的品系依赖性与糖尿病和炎症表型有关。
Liver Int. 2014 Aug;34(7):1084-93. doi: 10.1111/liv.12335. Epub 2013 Oct 25.

引用本文的文献

1
MASLD development: From molecular pathogenesis toward therapeutic strategies.代谢相关脂肪性肝病的发展:从分子发病机制到治疗策略
Chin Med J (Engl). 2025 Aug 5;138(15):1807-1824. doi: 10.1097/CM9.0000000000003629. Epub 2025 Jul 10.
2
CD4 T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis.CD4 T细胞在代谢功能障碍相关脂肪性肝炎期间促进纤维化。
bioRxiv. 2025 Jul 3:2025.06.27.660220. doi: 10.1101/2025.06.27.660220.
3
Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.

本文引用的文献

1
Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution.转录调控网络分析提示肝免疫功能紊乱在 NASH 的发生和转归中起重要作用。
Nat Metab. 2019 Jun;1(6):604-614. doi: 10.1038/s42255-019-0076-1. Epub 2019 Jun 14.
2
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.非酒精性脂肪性肝病、非酒精性脂肪性肝炎及相关纤维化的诊断方法。
Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.
3
Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide.
通过双向孟德尔随机化研究探讨免疫细胞在非酒精性脂肪性肝病中的因果作用。
Open Med (Wars). 2025 Feb 19;20(1):20251154. doi: 10.1515/med-2025-1154. eCollection 2025.
4
Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis.茨蓬医院HIV感染者的脂肪性肝病:一项尸检分析。
South Afr J HIV Med. 2024 Dec 20;25(1):1638. doi: 10.4102/sajhivmed.v25i1.1638. eCollection 2024.
5
Immunology and treatments of fatty liver disease.脂肪肝疾病的免疫学与治疗方法
Arch Toxicol. 2025 Jan;99(1):127-152. doi: 10.1007/s00204-024-03920-1. Epub 2024 Dec 18.
6
Ileal microbial microbiome and its secondary bile acids modulate susceptibility to nonalcoholic steatohepatitis in dairy goats.回肠微生物菌群及其次级胆汁酸可调节奶山羊非酒精性脂肪性肝炎易感性。
Microbiome. 2024 Nov 23;12(1):247. doi: 10.1186/s40168-024-01964-0.
7
Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.免疫系统在代谢功能障碍相关脂肪性肝病中的积极作用。
Gastroenterol Rep (Oxf). 2024 Oct 15;12:goae089. doi: 10.1093/gastro/goae089. eCollection 2024.
8
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.MASH 中的免疫动力学:从景观分析到治疗干预。
J Gastroenterol. 2024 Dec;59(12):1053-1078. doi: 10.1007/s00535-024-02157-0. Epub 2024 Oct 14.
9
Rodent model of metabolic dysfunction-associated fatty liver disease: a systematic review.代谢功能障碍相关脂肪性肝病的啮齿动物模型:一项系统综述
J Gastroenterol Hepatol. 2025 Jan;40(1):48-66. doi: 10.1111/jgh.16749. Epub 2024 Sep 25.
10
Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses.通过批量和单细胞转录组分析对非酒精性脂肪性肝病和动脉粥样硬化之间的共享风险基因及免疫代谢进行综合分析。
Heliyon. 2024 Jul 30;10(15):e35453. doi: 10.1016/j.heliyon.2024.e35453. eCollection 2024 Aug 15.
非酒精性脂肪性肝病动物模型:入门指南。
Nutrients. 2017 Sep 27;9(10):1072. doi: 10.3390/nu9101072.
4
Intrahepatic CD206 macrophages contribute to inflammation in advanced viral-related liver disease.肝内 CD206 巨噬细胞促进晚期病毒相关性肝病的炎症反应。
J Hepatol. 2017 Sep;67(3):490-500. doi: 10.1016/j.jhep.2017.04.023. Epub 2017 May 5.
5
Insights from engraftable immunodeficient mouse models of hyperinsulinaemia.胰岛素血症嵌合体免疫缺陷小鼠模型的研究进展。
Sci Rep. 2017 Mar 28;7(1):491. doi: 10.1038/s41598-017-00443-x.
6
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets.非酒精性脂肪性肝病中的免疫失衡:从一般生物标志物和中性粒细胞到白细胞介素-17轴激活及新治疗靶点
Front Immunol. 2016 Nov 11;7:490. doi: 10.3389/fimmu.2016.00490. eCollection 2016.
7
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.与非酒精性脂肪性肝病成人患者肝病严重程度相关的新型血浆生物标志物。
Hepatology. 2017 Jan;65(1):65-77. doi: 10.1002/hep.28776. Epub 2016 Oct 12.
8
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.比较非酒精性脂肪性肝病小鼠模型和患者肝组织的基因表达谱。
Gastroenterology. 2016 Sep;151(3):513-525.e0. doi: 10.1053/j.gastro.2016.05.051. Epub 2016 Jun 16.
9
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.一种饮食诱导的非酒精性脂肪性肝病和肝细胞癌动物模型。
J Hepatol. 2016 Sep;65(3):579-88. doi: 10.1016/j.jhep.2016.05.005. Epub 2016 May 31.
10
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.非酒精性脂肪性肝病导致选择性CD4(+) T淋巴细胞丢失并促进肝癌发生。
Nature. 2016 Mar 10;531(7593):253-7. doi: 10.1038/nature16969. Epub 2016 Mar 2.